VISTENDO INC — Department of Defense SBIR Phase II: DHA192-003

Description

The overall objective of the Phase II program is to develop and commercialize a portable, reliable, easy-to-use medical device called POMAS (Portable Oculomotor Multi-sensing Assessment System) (Figure 1) with associated software in order to enable non-invasive, fast, accurate and objective full spectrum oculomotor testing combined with 2 involuntary ANS (Autonomic Nervous System) measurements for TBI (including mTBI) assessment in various operational and training environments from ROC1 to ROC2. The POMAS is ruggedized for all-weather on-the-field operation, and uses Machine Learning (ML) algorithms to provide a simple assessment score for use by medics, buddy, or even the injured warfighter. Simply hold POMAS up to the injured warfighter’s eyes and, after only 15-30 seconds of gathering measurements, it can identify and assess the severity of TBI (none, mild, moderate, severe), displaying results both on a small screen and on their ATAK device. The detailed data can later be viewed by clinicians to localize injuries to the brain and nervous system, and the same device can be used to test the patient during treatment to measure recovery.